All-time high CME premiums ahead of ETF verdict

K33 Research Pro

For Professional and Institutional Investors

01 Jan 2024

All-time high CME premiums ahead of ETF verdict

Bitcoin hits $46,000 amid CME frenzy on ETF anticipation. Will the ETF approval be a 'sell the news' event, or will we continue up? We discuss the topic in this week's Ahead of the Curve.

Preview

Day to day movements will be hard to predict

We are expecting loads of price fluctuations in the coming weeks, but the short-term direction is hard to predict. The market will likely be jumpy on ETF news until they are approved, and once approved, it will be highly interesting to follow the market. The spot ETFs have certainly been front-run, but whether it has been too much will depend on the flows after approval. We will definitely see flows from inferior products to the spot ETFs, but the critical factor is the net inflow of new money.

K33 Research Pro

All-time high CME premiums ahead of ETF verdict

Day to day movements will be hard to predict

A possibility of down before up again

Share this article